42136 Lebrikizumab improvement in itch reduction at 52 weeks in patients with moderate-to-severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials
| Autor: | Yosipovitch, Gil, Lio, Peter, Rosmarin, David, Legat, Franz, Carrascosa, Jose Manuel, Meskimen, Eric, Casillas, Marta, Pierce, Evangeline, Liu, Zhuqing, Zhong, Jinglin, Ständer, Sonja |
|---|---|
| Zdroj: | In Journal of the American Academy of Dermatology September 2023 89(3) Supplement:AB188-AB188 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect